undamentalytics Newsletter
Sign in

Lam Research (LRCX) stock

Add to watchlist

Add holding +

NASDAQ: LRCX Nasdaq Semiconductor Materials & Equipment Next results ~January 27, 2027

B+ Fundamentals grade

Lam Research is a US-listed company in the semiconductor materials & equipment industry. Its financial year ends in June.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$220

Cash-flow model

Base case. Range ~$170–$290 across our lower- and higher-growth cases (8%–18% a year).

Price vs value

Modestly overvalued

The price is inside our value range, 3% above our base value.

Price used: $229.80, November 3, 2026

Lam Research valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

Value diary

Our note on each quarter Lam Research files

10-Q filed October 22: Lam Research

Rating: Sell to Hold Model value +28.5%

Revenue for the twelve months to September 2026 reached $26.1bn, up 33.4% on a year earlier and faster than the 26.0% posted a quarter before. That pace ranks 81 of 934 among the companies we cover. Operating margin widened to 37.0% from 33.0%, though free-cash-flow margin slipped to 25.0% from 28.3% a year earlier. On the back of this, the fundamentals grade moves from B to B+. Our model value rises from $176 to $226 a share, set against a share price of $230, and the rating shifts from Sell to Hold. At that price, the model implies the market is pricing in about 18.2% a year of cash-flow growth for five years, well ahead of the 8.7% a year revenue growth delivered.

Source: 10-Q filed October 22, 2026 on SEC EDGAR · Financials · Valuation

Earlier notes (1)

Where Lam Research stands after its latest 10-K

Revenue for the twelve months to June 2026 was $23.2bn, up 26.0% on a year earlier, slower than 26.5% a quarter earlier. That growth ranks 123 of 931 among all the companies we cover. Free-cash-flow margin fell to 21.1% from 29.4% a year earlier. Operating margin widened to 35.3% from 32.0%. The diluted share count is down 2.3% on a year earlier, which lifts each remaining share. Against its peers on growth, profitability, cash generation and balance sheet, it grades B. It passes 7 of our 7 financial-health checks. Our cash-flow model value is $131 a share, against a share price of $265. At that price, our model says the market is pricing in about 25.0% a year of cash-flow growth for five years, faster than the 9.7% a year revenue growth it has delivered.

10-K on SEC EDGAR

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~January 27, 2027 (estimated)

Lam Research's trailing-twelve-month revenue grew 33.4% year on year, with a free-cash-flow margin of 25.0%. Where it stands out: operating margin of 37.0% ranks 1 of 19 semiconductor materials & equipment companies we cover.

Our discounted-cash-flow model values the business at ~$220 per share in the base case (~$170–$290 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 17.8% while net income grew 45.4%: a 28pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 33.4% over the last 12 months, against a median of 15.8% for semiconductor materials & equipment companies we cover.
  • Growth speeding up. The growth rate is 7.3 points higher than a quarter earlier.
  • High operating margin. 37.0% of revenue is left as operating profit, against a median of 13.2% for semiconductor materials & equipment companies we cover.
  • Margins widening. Operating margin is up 3.9 points on a year ago.
  • Strong cash generation. 25.0% of revenue turned into free cash flow, against a median of 17.5% for semiconductor materials & equipment companies we cover.

Things to watch

  • Volatile shares. Over the past year the shares showed annualised volatility of 66% and a beta of 3.3 against the S&P 500.
  • Insiders selling. 8 insiders sold $176M of stock over the past 365 days and none bought (77% under pre-set trading plans).
  • Weak cash conversion. Free cash flow was 77% of net income over the last 12 months.

Latest results: FY2027 Q1

Filed October 22, 2026
Earnings per share
$2.20 against an average estimate of $2.18: beat by 0.9%
Revenue
$8.22bn, up 54.4% on a year earlier
Share reaction
-12.6% in the first session after the results on October 21, 2026, against -0.7% for the S&P 500
Guidance given
revenue $8.6bn (quarter ending December 27, 2026); revenue $8.6bn (quarter ending December 27, 2026)
Next report
October 21, 2026; average EPS estimate $2.35

Lam Research's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+1.0%
  • 1 week-4.6%
  • 1 month-33.9%
  • This year+33.3%
  • 1 year+43.2%
  • 5 years+303.8%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$26.1B
Operating margin
37.0%
Net margin
32.3%
EPS (TTM, diluted)
$6.72

Growth

Revenue growth
+33.4%
Change in growth rate
+7.3 pts
Share count change
−1.9%

Cash

Free cash flow (TTM)
$6.5B
FCF margin
25.0%
Stock pay % of revenue
1.5%

Earnings

Last results
October 21, 2026
Next results (est.)
January 27, 2027

News & updates

Updated November 2, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Our research
  2. Insider trade
  3. Results
  4. Guidance
  5. Insider trade
  6. Insider trade
  7. Insider trade
  8. Insider trade
  9. Leadership
  10. Dividend
  11. Announcement
  12. Insider trade
  13. Results
  14. Insider trade

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Lam Research valuation models and calculator

What the price is pricing in

The share price implies about 18.1% a year of cash-flow growth for five years.That is faster than the 8.7% a year revenue growth Lam Research has delivered.

  • Priced in18.1%
  • Last 12 months33.4%
  • 3 years a year18.2%
  • 5 years a year8.7%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($229.79, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Hold12-month view
12-month price target
~$220
Price used
$229.79close November 3, 2026
Implied change
▼ 3%
Uncertainty
Medium

How we got here: a discounted-cash-flow model of Lam Research's free cash flow after stock-based pay with after-tax interest added back ($6.9B, FY2027 Q1 TTM), growing 38.5% and 15.7% in the next two years (forecasts, guidance and its record), then back to 13% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$170–~$290 ; that spread sets a 25% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Lam Research's free cash flow after stock-based pay ( $6.9B, FY2027 Q1 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Lam Research as an operating company, with every model that fits that kind of business. Cost of equity 12.6%: the 10-year Treasury yield (4.9%) plus a beta of 1.71 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$220 ~$170–$290 Primary model, counts double
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$99 ~$67–$130 Included
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$200 ~$170–$260 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: return on equity above 40%: buybacks or intangibles make book value too small an anchor
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$43 ~$39–$48 Left out: out of range vs price (0.19x)
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$190 ~$99–$220 3 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Lam Research with Semiconductor Materials & Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −24%
  • Revenue growth 5 points higher ▲ +30%
  • Free-cash-flow margin 1 point lower ▼ −4%
  • Last year's free-cash-flow margin change, if it persists ▼ −11%
  • Discount rate 1 point higher ▼ −16%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $83$112$150$200$265$349
8.5% $64$85$112$148$195$254
10% $53$69$90$117$153$198

Valuation multiples over time Market data may be delayed

At fiscal year end 20162017201820192020202120222023202420252026Now
Share price$7.18$13.43$15.67$17.28$28.38$59.78$43.17$59.20$104.57$96.56$378.69$227.56
Market value$12.6bn$24.7bn$28.3bn$27.6bn$42.3bn$86.9bn$60.7bn$80.4bn$138.0bn$124.6bn$477.6bn$286.2bn
+ Net debt (− = net cash)−$489m$501m−$4.5bn$854m$933m$583m$1.5bn−$326m−$848m−$1.9bn−$1.8bn−$3.7bn
Enterprise value$12.1bn$25.2bn$23.8bn$28.5bn$43.2bn$87.5bn$62.2bn$80.1bn$137.2bn$122.7bn$475.7bn$282.5bn
Multiples
Price / sales 2.1x3.1x2.6x2.9x4.2x5.9x3.5x4.6x9.3x6.8x20.6x11.0x
Price / earnings 13.8x14.5x11.9x12.6x18.8x22.2x13.2x17.8x36.1x23.3x65.7x33.9x
Price / free cash flow 10.7x13.2x11.9x9.6x22.0x26.8x23.8x17.2x32.4x23.0x97.6x43.8x
EV / EBITDA 8.9x11.4x6.7x10.3x14.7x18.3x10.9x14.5x29.7x19.5x55.1x27.9x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

95 /100

Strong moat

How hard Lam Research's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 20 / 20

    Cash operating profit has been a median 33.9% of total assets over 10 years.

  • Pricing power 16 / 20

    Gross margin has been a median 46.3%, moving by 1.9 percentage points (standard deviation) across 10 years.

  • Durability 20 / 20

    Operating margin has been a median 28.7%; its worst year was 25.4%.

  • Cash conversion 20 / 20

    Free cash flow was positive in 10 of 10 years, at a median 25.1% of revenue.

  • Discipline 20 / 20

    The diluted share count fell 15.2% over five years; stock-based pay has been a median 1.8% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $9.63 +65% $35.4bn +52%
Next $12.15 +26% $42.6bn +20%

Next year's EPS estimate has moved +19.7% in 90 days, across 28 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +17.2% on 90 days ago. In the last 30 days, 2 analysts raised Lam Research's forecast and 0 cut it.

Consensus EPS forecast Lam Research, last 90 days
$8.00 $9.00 $10.00 $11.00 $12.00 $13.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $8.22 Current fiscal year, 60 days ago: $9.46 Current fiscal year, 30 days ago: $9.47 Current fiscal year, 7 days ago: $9.49 Current fiscal year, Now: $9.63 $9.63 Next fiscal year, 90 days ago: $10.16 Next fiscal year, 60 days ago: $11.56 Next fiscal year, 30 days ago: $11.74 Next fiscal year, 7 days ago: $11.91 Next fiscal year, Now: $12.15 $12.15

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $8.22$10.16
60 days ago $9.46$11.56
30 days ago $9.47$11.74
7 days ago $9.49$11.91
Now $9.63$12.15

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $2.18 $2.20 +0.9%
Jun 2026 $1.68 $1.82 +8.1%
Mar 2026 $1.36 $1.47 +7.9%
Dec 2025 $1.17 $1.27 +8.7%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 21, 2026
  • Revenue quarter ending December 27, 2026 about $8.6bn GAAP Raised vs about 8.1bn
    “Revenue $8.60 Billion +/- $400 Million - $8.60 Billion +/- $400 Million” source
  • Revenue quarter ending December 27, 2026 about $8.6bn Non-GAAP Raised vs about 8.1bn
    “Revenue $8.60 Billion +/- $400 Million - $8.60 Billion +/- $400 Million” source
  • Net income per diluted share quarter ending December 27, 2026 about $2.33 GAAP Raised vs about 2.15
    “Net income per diluted share $2.33 +/- $0.15 $ 3.3 Million $2.33 +/- $0.15” source
  • Net income per diluted share quarter ending December 27, 2026 about $2.33 Non-GAAP Raised vs about 2.15
    “Net income per diluted share $2.33 +/- $0.15 $ 3.3 Million $2.33 +/- $0.15” source
  • Gross margin quarter ending December 27, 2026 about 52.5% GAAP Raised vs about 52
    “Gross margin 52.5% +/- 1% $ 2.7 Million 52.5% +/- 1%” source
  • Gross margin quarter ending December 27, 2026 about 52.5% Non-GAAP Raised vs about 52
    “Gross margin 52.5% +/- 1% $ 2.7 Million 52.5% +/- 1%” source
Show 4 more items
  • Operating margin quarter ending December 27, 2026 about 40.5% GAAP Raised vs about 39.5
    “Operating margin 40.5% +/- 1% $ 3.0 Million 40.5% +/- 1%” source
  • Operating margin quarter ending December 27, 2026 about 40.5% Non-GAAP Raised vs about 39.5
    “Operating margin 40.5% +/- 1% $ 3.0 Million 40.5% +/- 1%” source
  • Diluted share count quarter ending December 27, 2026 about 1.253bn GAAP
    “Diluted share count 1.253 Billion - 1.253 Billion” source
  • Diluted share count quarter ending December 27, 2026 about 1.253bn Non-GAAP
    “Diluted share count 1.253 Billion - 1.253 Billion” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

How our valuation uses these forecasts

Our cash-flow model grows Lam Research's revenue by +38.5% next year and +15.7% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+42.3%, weight 57%) , management guidance (+60.9%, weight 18%) and the company's own record (+13.0%, weight 24%) . How the weights are set.

Analyst recommendations

34 analysts, Oct 2026
Buy3088%
Hold412%
Sell00%

Monthly trend

  1. Oct 2026525434
  2. Sep 2026425635
  3. Aug 2026425635
  4. Jul 2026425635

Counts of recommendations published by analysts covering Lam Research, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
2.3%
of tradable shares
Days to cover
3.15
at average volume
Short interest, 1 month
+9%
to October 15, 2026
Held by institutions
89%
of shares
Held by insiders
0.3%
of shares
Employees
24,300
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +45.2%

$156.74 on October 31, 2025 to $227.56

ThenNowEffect
Revenue (last 12 months) $18.4bn $23.2bn +26.0%
Net margin 29.1% 31.3% +7.6%
P/E multiple 37.7x 39.5x +4.7%
Share count 1290m 1261m +2.3%

Biggest factor: revenue.

Last 3 years +267.9%

$61.85 on November 3, 2023 to $227.56

ThenNowEffect
Revenue (last 12 months) $17.4bn $23.2bn +33.3%
Net margin 25.9% 31.3% +20.8%
P/E multiple 18.8x 39.5x +110.6%
Share count 1368m 1261m +8.5%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
LRCX+54%−41%+89%−7%+139%+33%
Industry peers (median)+67%−36%+29%+0%+27%+26%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
LRCX67%33%58%42%58%64%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
LRCX−18%−56%−19%−38%−33%−47%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 56% from January 14, 2022 to October 14, 2022. Getting back needed a 129% gain, reached on July 28, 2023, 287 days after the low.

Price behaviour

52-week range
$138.95 – $432.87
From 52-week high
−47.4%
vs 50-day average
−22.2%
vs 200-day average
−19.8%
Volatility (1 year)
66%
Beta vs S&P 500
3.32

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
9 up, 3 down
typical move ±5.5%
After a week
5 up, 7 down
typical move ±7.5%
After a month
8 up, 3 down
typical move ±9.6%
Results releasedNext dayS&P 500 next day5 days21 days
October 21, 2026 −12.6% −0.7% −3.7% —
July 29, 2026 +10.4% +0.1% +14.0% +18.2%
April 22, 2026 +0.1% +0.6% −3.7% +17.0%
January 28, 2026 +4.1% −0.2% −12.0% −1.9%
October 22, 2025 +1.7% +0.1% +10.8% −3.8%
July 30, 2025 −4.1% −0.5% −3.0% +5.2%
April 23, 2025 +11.7% +3.7% +12.9% +30.1%
January 29, 2025 +8.3% +0.1% +10.0% +3.0%
October 23, 2024 +4.9% −0.7% +4.7% +0.2%
July 31, 2024 −2.9% +0.2% −12.5% −6.7%
April 24, 2024 +1.6% −0.4% −2.2% +8.0%
January 24, 2024 +4.2% +0.7% −0.6% +11.8%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Options strategies

All options ideas

How Lam Research’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 3, 2026. Check the live chain at your broker before trading.

Implied vs realised volatility

Options look fairly priced

Implied volatility is within its normal range against realised. Selling options earns the usual premium, nothing extra.

  • Implied is 1.03× the last 60 days’ realised volatility , richer than 21% of the 175 stocks we screen today.
  • Puts and calls are priced at about the same implied volatility.
  • Why: implied is not far enough above realised, or not unusual against our coverage.

Our rule for “rich”: implied at least 1.2× 60-day realised (beyond measurement noise), above 1-year realised (not just a calm spell), and in the top 20% of our coverage that day. Never with results inside the option’s life. These are our conventions, built on research showing option prices usually imply more movement than follows, most when the gap is wide. How we judge this.

LRCX Lam Research Grade B+ $230.21

Sell the $215 put expiring December 4, 2026 (31 days) for $9.15 a share — $915 per contract.

Bid $9.15, ask $10.50, quoted Tue 3 Nov, 14:33 New York time with LRCX at $230.21. Option prices move with the shares: check the live chain at your broker before trading.

  • If LRCX ends above $215: you keep the $915 — 4.3% on the $21,500 set aside, or 50.1% a year at that pace.
  • If it ends below $215: you buy 100 shares at an effective $205.85, 11% below today's price and 6% below our value of ~$220.
$915 $0 −$4.1k Break-even $205.85 Our value $220 Price $230.21
Profit or loss per contract at expiry, by share price.
Premium
$915
Annualised
50.1%
Break-even
$205.85
Max gain
$915
Chance of buying
~31%
LRCX Lam Research Grade B+ $230.21

Own 100 shares, sell the $260 call expiring December 11, 2026 (38 days) for $6.70 a share — $670 per contract.

Bid $6.70, ask $8.50, quoted Tue 3 Nov, 14:33 New York time with LRCX at $230.21. Option prices move with the shares: check the live chain at your broker before trading.

  • If LRCX ends below $260: you keep your shares and the $670 — 2.9% extra on the position, 28.0% a year at that pace.
  • If it ends above $260: your shares are sold at $260, a total return of 15.9% including the premium — at or above our value of ~$220.
$3.6k $0 −$4.5k Our value $220 Break-even $223.51 Price $230.21
Profit or loss per contract at expiry, by share price (including the shares bought at today's price).
Premium
$670
Annualised
28.0%
Break-even
$223.51
Max gain
$3,649.5
Chance of selling
~31%

Collar

Own the shares, buy the $215 put and sell the $265 call, both expiring December 4, 2026 (31 days).

  • Net cost of $5.70 a share ($570 per contract of 100 shares).
  • Worst case at expiry: -9.1%, if the shares fall below $215 (-6.6% from today).
  • Best case at expiry: +12.6%, if the shares rise above $265 (+15.1%); gains beyond that go to the call buyer.

Offered because the shares trade at or above our fair value of $220: a way to hold on with a floor under the price, paid for by giving up upside the model does not expect. Strikes near 25-delta; the put at its ask and the call at its bid. Protection has a cost over time: research on protective puts finds they have usually lowered returns.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Lam Research in five measures

Fundamentals grade B+
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Lam Research
$10B $15B $20B $25B $30B FY24 Q2 FY25 Q1 FY25 Q4 FY27 Q1 Revenue (TTM), FY24 Q2: $14.3B Revenue (TTM), FY24 Q3: $14.2B Revenue (TTM), FY24 Q4: $14.9B Revenue (TTM), FY25 Q1: $15.6B Revenue (TTM), FY25 Q2: $16.2B Revenue (TTM), FY25 Q3: $17.1B Revenue (TTM), FY25 Q4: $18.4B Revenue (TTM), FY26 Q1: $19.6B Revenue (TTM), FY26 Q2: $20.6B Revenue (TTM), FY26 Q3: $21.7B Revenue (TTM), FY26 Q4: $23.2B Revenue (TTM), FY27 Q1: $26.1B $26.1B

Source: SEC EDGAR filings. Retrieved October 23, 2026.

View chart data
Period Revenue (TTM)
FY24 Q2 $14.3B
FY24 Q3 $14.2B
FY24 Q4 $14.9B
FY25 Q1 $15.6B
FY25 Q2 $16.2B
FY25 Q3 $17.1B
FY25 Q4 $18.4B
FY26 Q1 $19.6B
FY26 Q2 $20.6B
FY26 Q3 $21.7B
FY26 Q4 $23.2B
FY27 Q1 $26.1B
Revenue growth, TTM YoY Lam Research
-40% -20% 0% 20% 40% FY24 Q2 FY25 Q1 FY25 Q4 FY27 Q1 Revenue growth, TTM YoY, FY24 Q2: -24.8% Revenue growth, TTM YoY, FY24 Q3: -24.5% Revenue growth, TTM YoY, FY24 Q4: -14.5% Revenue growth, TTM YoY, FY25 Q1: -1.5% Revenue growth, TTM YoY, FY25 Q2: 13.2% Revenue growth, TTM YoY, FY25 Q3: 20.3% Revenue growth, TTM YoY, FY25 Q4: 23.7% Revenue growth, TTM YoY, FY26 Q1: 25.7% Revenue growth, TTM YoY, FY26 Q2: 26.8% Revenue growth, TTM YoY, FY26 Q3: 26.5% Revenue growth, TTM YoY, FY26 Q4: 26.0% Revenue growth, TTM YoY, FY27 Q1: 33.4% 33.4%

Source: SEC EDGAR filings. Retrieved October 23, 2026.

View chart data
Period Revenue growth, TTM YoY
FY24 Q2 -24.8%
FY24 Q3 -24.5%
FY24 Q4 -14.5%
FY25 Q1 -1.5%
FY25 Q2 13.2%
FY25 Q3 20.3%
FY25 Q4 23.7%
FY26 Q1 25.7%
FY26 Q2 26.8%
FY26 Q3 26.5%
FY26 Q4 26.0%
FY27 Q1 33.4%
Operating margin (TTM) Lam Research
25% 30% 35% 40% FY24 Q2 FY25 Q1 FY25 Q4 FY27 Q1 Operating margin (TTM), FY24 Q2: 27.1% Operating margin (TTM), FY24 Q3: 28.0% Operating margin (TTM), FY24 Q4: 28.6% Operating margin (TTM), FY25 Q1: 28.9% Operating margin (TTM), FY25 Q2: 29.5% Operating margin (TTM), FY25 Q3: 30.9% Operating margin (TTM), FY25 Q4: 32.0% Operating margin (TTM), FY26 Q1: 33.0% Operating margin (TTM), FY26 Q2: 33.8% Operating margin (TTM), FY26 Q3: 34.3% Operating margin (TTM), FY26 Q4: 35.3% Operating margin (TTM), FY27 Q1: 37.0% 37.0%

Source: SEC EDGAR filings. Retrieved October 23, 2026.

View chart data
Period Operating margin (TTM)
FY24 Q2 27.1%
FY24 Q3 28.0%
FY24 Q4 28.6%
FY25 Q1 28.9%
FY25 Q2 29.5%
FY25 Q3 30.9%
FY25 Q4 32.0%
FY26 Q1 33.0%
FY26 Q2 33.8%
FY26 Q3 34.3%
FY26 Q4 35.3%
FY27 Q1 37.0%
FCF margin (TTM) Lam Research
20% 25% 30% 35% FY24 Q2 FY25 Q1 FY25 Q4 FY27 Q1 FCF margin (TTM), FY24 Q2: 34.0% FCF margin (TTM), FY24 Q3: 31.9% FCF margin (TTM), FY24 Q4: 28.6% FCF margin (TTM), FY25 Q1: 31.0% FCF margin (TTM), FY25 Q2: 25.0% FCF margin (TTM), FY25 Q3: 22.1% FCF margin (TTM), FY25 Q4: 29.4% FCF margin (TTM), FY26 Q1: 28.3% FCF margin (TTM), FY26 Q2: 30.2% FCF margin (TTM), FY26 Q3: 27.7% FCF margin (TTM), FY26 Q4: 21.1% FCF margin (TTM), FY27 Q1: 25.0% 25.0%

Source: SEC EDGAR filings. Retrieved October 23, 2026.

View chart data
Period FCF margin (TTM)
FY24 Q2 34.0%
FY24 Q3 31.9%
FY24 Q4 28.6%
FY25 Q1 31.0%
FY25 Q2 25.0%
FY25 Q3 22.1%
FY25 Q4 29.4%
FY26 Q1 28.3%
FY26 Q2 30.2%
FY26 Q3 27.7%
FY26 Q4 21.1%
FY27 Q1 25.0%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2026, from the 10-K

Each dollar Lam Research took in during FY2026, followed through to profit: what it cost to make, what went on research and running the business, and what was left after tax.

  1. Revenue $23.2B
  2. Cost of revenue $11.5B · 49.5%
  3. Gross profit $11.7B · 50.5%
  4. Research and development $2.4B · 10.2%
  5. Selling, general and admin $1.1B · 4.9%
  6. Operating income $8.2B · 35.3%
  7. Income tax $997M · 4.3%
  8. Net income $7.3B · 31.3%

Shares of revenue. Source: Lam Research's 10-K for FY2026, as filed with the SEC.

Financial statements

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2010 Jun 2010 2011 Jun 2011 2012 Jun 2012 2013 Jun 2013 2014 Jun 2014 2015 Jun 2015 2016 Jun 2016 2017 Jun 2017 2018 Jun 2018 2019 Jun 2019 2020 Jun 2020 2021 Jun 2021 2022 Jun 2022 2023 Jun 2023 2024 Jun 2024 2025 Jun 2025 2026 Jun 2026 LTM Sept 2026
Income
Revenue 2.1 3.2 2.7 3.6 4.6 5.3 5.9 8.0 11.1 9.7 10.0 14.6 17.2 17.4 14.9 18.4 23.2 26.1
Gross profit 1.0 1.5 1.1 1.4 2.0 2.3 2.6 3.6 5.2 4.4 4.6 6.8 7.9 7.8 7.1 9.0 11.7 13.3
EBITDA 0.5 0.9 0.3 0.4 1.0 1.1 1.4 2.2 3.5 2.8 2.9 4.8 5.7 5.5 4.6 6.3 8.6 10.1
Operating income 0.4 0.8 0.2 0.1 0.7 0.8 1.1 1.9 3.2 2.5 2.7 4.5 5.4 5.2 4.3 5.9 8.2 9.7
Net income 0.3 0.7 0.2 0.1 0.6 0.7 0.9 1.7 2.4 2.2 2.3 3.9 4.6 4.5 3.8 5.4 7.3 8.4
Diluted EPS $0.27 $0.58 $0.14 $0.07 $0.36 $0.37 $0.52 $0.92 $1.32 $1.37 $1.51 $2.69 $3.27 $3.32 $2.90 $4.15 $5.76 $6.72
Growth (year on year)
Revenue +91.2% +51.7% −17.7% +35.0% +28.0% +14.2% +11.9% +36.1% +38.2% −12.9% +4.1% +45.6% +17.8% +1.2% −14.5% +23.7% +26.0% +33.4%
EBITDA — +76.9% −61.5% +24.7% +129.7% +9.9% +28.1% +61.8% +60.2% −21.6% +6.1% +62.8% +19.3% −3.5% −16.2% +36.0% +37.4% +47.5%
Operating income — +89.1% −70.4% −50.3% +474.0% +16.3% +36.3% +77.1% +68.9% −23.3% +8.5% +67.6% +20.1% −3.8% −17.6% +38.4% +39.0% +49.3%
Net income — +108.8% −76.7% −32.5% +455.2% +3.7% +39.4% +85.7% +40.2% −7.9% +2.8% +73.6% +17.8% −2.0% −15.1% +40.0% +35.6% +45.4%
Diluted EPS — +113.7% −76.7% −51.1% +448.5% +2.2% +41.1% +77.0% +42.5% +4.0% +10.2% +78.1% +21.7% +1.4% −12.7% +43.1% +38.8% +48.2%
Margins
Gross margin 45.5% 46.2% 40.7% 39.0% 43.6% 43.4% 44.5% 45.0% 46.6% 45.1% 45.9% 46.5% 45.7% 44.6% 47.3% 48.7% 50.5% 51.1%
EBITDA margin 23.3% 27.2% 12.7% 11.7% 21.1% 20.3% 23.2% 27.6% 32.0% 28.7% 29.3% 32.7% 33.2% 31.7% 31.0% 34.1% 37.2% 38.7%
Operating margin 19.9% 24.8% 8.9% 3.3% 14.7% 15.0% 18.3% 23.7% 29.0% 25.5% 26.6% 30.6% 31.2% 29.7% 28.6% 32.0% 35.3% 37.0%
Net margin 16.2% 22.4% 6.3% 3.2% 13.7% 12.5% 15.5% 21.2% 21.5% 22.7% 22.4% 26.7% 26.7% 25.9% 25.7% 29.1% 31.3% 32.3%
Free-cash-flow margin 14.8% 23.3% 14.7% 15.5% 12.4% 11.2% 20.0% 23.4% 21.5% 29.8% 19.1% 22.1% 14.8% 26.8% 28.6% 29.4% 21.1% 25.0%
Cash flow
Cash from operations 0.4 0.9 0.5 0.7 0.7 0.8 1.4 2.0 2.7 3.2 2.1 3.6 3.1 5.2 4.7 6.2 5.9 7.6
Capital spending 0.0 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.3 0.3 0.2 0.3 0.5 0.5 0.4 0.8 1.0 1.0
Free cash flow 0.3 0.8 0.4 0.6 0.6 0.6 1.2 1.9 2.4 2.9 1.9 3.2 2.6 4.7 4.3 5.4 4.9 6.5
Stock-based pay 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.4 0.4
Free cash flow after stock pay 0.3 0.7 0.3 0.5 0.5 0.5 1.0 1.7 2.2 2.7 1.7 3.0 2.3 4.4 4.0 5.1 4.5 6.1
Balance sheet
Cash 0.5 1.5 1.6 1.2 1.5 1.5 5.0 2.4 4.5 3.7 4.9 4.4 3.5 5.3 5.8 6.4 5.6 7.4
Total debt 0.0 0.9 — 1.3 1.3 2.6 4.5 2.9 — 4.5 5.8 5.0 5.0 5.0 5.0 4.5 3.8 3.7
Net debt (negative = net cash) −0.5 −0.6 −1.6 0.1 −0.1 1.1 −0.5 0.5 −4.5 0.9 0.9 0.6 1.5 −0.3 −0.8 −1.9 −1.8 −3.7
Diluted shares 1,281m 1,250m 1,252m 1,734m 1,745m 1,771m 1,752m 1,838m 1,808m 1,599m 1,491m 1,453m 1,406m 1,358m 1,320m 1,290m 1,261m 1,258m
Returned to shareholders
Dividends — — — — 0.0 0.1 0.2 0.2 0.3 0.7 0.7 0.7 0.8 0.9 1.0 1.1 1.3 1.3
Buybacks 0.1 0.2 0.8 1.0 0.2 0.6 0.2 0.8 2.7 3.8 1.4 2.7 3.9 2.0 2.8 3.4 3.9 3.9
Total returned 0.1 0.2 0.8 1.0 0.2 0.7 0.3 1.1 3.0 4.5 2.0 3.4 4.7 2.9 3.9 4.6 5.1 5.2

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

7 of 7 checks passed · September 27, 2026
What it owns · $26.4bn
Short-term assets $18.1bnLonger-term assets $8.2bn
What it owes, and who funded it · $26.4bn
Short-term liabilities $7.3bnLonger-term liabilities $5.1bnShareholders' equity $13.9bn
  • Short-term assets cover short-term liabilities $18.1bn of assets due within a year against $7.3bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $18.1bn short-term assets against $5.1bn of longer-dated liabilities.
  • More cash than debt $7.4bn of cash against $3.7bn of debt.
  • Debt below 40% of shareholders' equity Debt is 27% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 82% to 27% over five years.
  • A year's operating cash flow covers at least 20% of debt $7.6bn of operating cash flow against $3.7bn of debt.
  • Operating profit covers interest at least five times over Operating income of $9.7bn against $151m of interest.

From Lam Research's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2027 Q1 TTM
Buybacks (TTM)
$3.9B
Dividends (TTM)
$1.3B
Returned to shareholders
80%
of free cash flow
Buybacks, last 3 fiscal years
$10.1B
Diluted share count
−1.9%
year over year
Total shareholder yield
1.8%
dividends 0.5% + buybacks 1.4% of market value
Dividend payout ratio
15%
of net income paid out
R&D spending
9.4%
of revenue
Sales & admin spending
4.7%
of revenue
Days sales outstanding
79 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in semiconductor materials & equipment
Last 12 months unless stated LRCX AMAT ASML KLAC TER MKSI Median
Revenue, last 12 months $26.1bn $30.8bn $36.9bn $14.5bn $5.0bn $4.3bn $994m
Revenue growth, last 12 months 33.4% 7.8% 20.8% 15.8% 74.9% 16.3% 15.8%
Revenue growth, 3-year average 18.2% 5.1% 74.4% 12.6% 22.2% 4.2% 7.8%
Revenue growth, latest quarter 54.4% 24.8% — 28.9% 69.8% 28.3% 33.7%
Gross margin 51.1% 49.4% 52.8% 61.5% 59.3% 47.0% 47.7%
Operating margin 37.0% 29.6% 34.6% 22.6% 32.1% 15.7% 13.2%
Operating margin, 3-year average 32.9% 29.6% 32.7% 26.1% 23.5% 13.3% 16.0%
Net margin 32.3% 30.1% 29.4% 36.2% 27.5% 10.1% 10.9%
Cash from operations / revenue 29.0% 27.2% 38.7% 31.1% 26.6% 14.6% 18.6%
Free-cash-flow margin 25.0% 18.2% 33.8% 27.8% 20.5% 10.5% 15.0%
Free-cash-flow margin, 3-year average 28.1% 21.0% 34.4% 29.8% 17.7% 12.2% 11.9%
Stock pay / revenue 1.5% 2.3% 0.6% 2.2% 1.6% 1.3% 2.4%
Change in share count −1.9% −2.0% −1.2% −4.5% −2.2% 3.3% 0.8%

Median of all 20 companies we cover in semiconductor materials & equipment. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

20 semiconductor materials & equipment companies
Measure Company Peer median Rank
Revenue growth Growth 33.4% 15.8% 5 of 20
Change in growth rate Growth +7.3pp +7.5pp 11 of 20
Gross margin Profitability 51.1% 48.2% 6 of 19
Operating margin Profitability 37.0% 13.2% 1 of 19
Net margin Profitability 32.3% 11.1% 2 of 20
Free-cash-flow margin Cash generation 25.0% 17.5% 5 of 20
Stock pay as % of revenue Cash generation 1.5% 2.5% 5 of 20
Long-term debt as % of assets Balance sheet 14.2% 22.0% 5 of 13
Change in share count Balance sheet -1.9% 0.9% 4 of 19
Days sales outstanding Balance sheet 79 days 79 days 9 of 16

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to June 28, 2026
Products and services
Line of business Revenue Share YoY
System $14.9B 64.1% ▲ 29.5%
Customer Support and Other $8.3B 35.9% ▲ 20.2%
Geography
Region Revenue Share YoY
China $7.9B 33.8% ▲ 26.7%
Taiwan $5.2B 22.5% ▲ 51.6%
South Korea $4.5B 19.4% ▲ 9.1%
Japan $2.2B 9.3% ▲ 15.4%
United States $1.5B 6.6% ▲ 11.0%
South East Asia $1.2B 5.4% ▲ 48.8%
Europe $699M 3.0% ▲ 24.2%

From Lam Research's 10-K filed August 7, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$463B
Institutions reporting
3,097
Shares held vs prior quarter
▲ 3.5%
Positions opened / closed
575 / 92

Top buyers and sellers, Q2 2026: 1,636 institutions bought and 1,244 sold ; the biggest buyer was Jpmorgan Chase & Co (+12.6M shares) and the biggest seller Artisan Partners Limited Partnership (−4.2M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $57.5B 132.7M 12.4% ▼ 0.1%
Vanguard Capital Management LLC $35.4B 81.7M 7.6% ▲ 0.7%
State Street Corp $26.3B 60.7M 5.7% ▲ 2.6%
Invesco Ltd. $22.7B 52.3M 4.9% ▲ 3.7%
Jpmorgan Chase & Co $18.6B 45.3M 4.0% ▲ 38.5%
Vanguard Portfolio Management LLC $15.9B 36.6M 3.4% ▼ 1.1%
Geode Capital Management, LLC $14.9B 34.5M 3.2% ▼ 1.9%
FMR LLC $14.6B 33.7M 3.2% ▲ 0.3%
Price T Rowe Associates Inc $10.7B 24.6M 2.3% ▲ 85.8%
Morgan Stanley $8.3B 19.2M 1.8% ▲ 1.3%
Norges Bank $7.9B 18.1M 1.7% —
Ameriprise Financial Inc $7.5B 17.3M 1.6% ▼ 16.6%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Lam Research's complete shareholder register. Values are as reported by the filers ; 10 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $176M 67 trades by 8 insiders · 77% under pre-set plans
Net ▼ $176M net selling
Insider Date Trade Shares Price Value
Archer Timothy President and CEO October 23, 2026 Sell pre-set plan 31,400 $227.02 $7.1M
Mayer Bethany Director September 9, 2026 Sell 9,557 $314.74 $3M
Archer Timothy President and CEO September 9, 2026 Sell pre-set plan 30,000 $319.26 $9.6M
Varadarajan Seshasayee Senior Vice President September 2, 2026 Sell pre-set plan 27,480 $291.32 $8M
Varadarajan Seshasayee Senior Vice President September 2, 2026 Sell pre-set plan 12,270 $291.32 $3.6M
Varadarajan Seshasayee Senior Vice President September 2, 2026 Sell pre-set plan 20,000 $291.32 $5.8M
Harter Ava Chief Legal Officer August 31, 2026 Sell pre-set plan 5,000 $302.46 $1.5M
Archer Timothy President and CEO August 6, 2026 Sell pre-set plan 30,000 $300.00 $9M
Talwalkar Abhijit Y Director July 13, 2026 Sell pre-set plan 18,282 $335.00 $6.1M
Archer Timothy President and CEO July 2, 2026 Sell pre-set plan 30,000 $390.01 $11.7M
Brandt Eric Director June 12, 2026 Sell pre-set plan 1,600 $373.09 $596,944
Brandt Eric Director June 12, 2026 Sell pre-set plan 7,700 $372.23 $2.9M

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 72 trades and filings

In the last 12 months, 2 members of Congress disclosed 3 purchases and 8 sales of Lam Research shares.

  • David J. Taylor(R-OH 2):Purchase, $1,001 - $15,000, traded October 15, 2026, filed October 29, 2026
  • David J. Taylor(R-OH 2):Sale (full), $1,001 - $15,000, traded June 5, 2026, filed June 12, 2026
  • David J. Taylor(R-OH 2):Sale (full), $1,001 - $15,000, traded April 27, 2026, filed May 7, 2026

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around January 27, 2027 estimated from the company's past filing pattern, not announced

  • October 21, 2026
  • July 29, 2026
  • April 22, 2026
  • January 28, 2026
  • October 22, 2025
  • July 30, 2025

Recent SEC filings

Data status

When each part of this page on Lam Research was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Lam Research in brief

What does Lam Research do?
Lam Research is a US-listed company in the semiconductor materials & equipment industry. Its financial year ends in June.
What is Lam Research's stock ticker?
Lam Research trades under the ticker LRCX on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Lam Research's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Lam Research reported revenue of $26.1B, 33.4% higher than a year earlier, according to its SEC filings.
What is Lam Research's free cash flow?
Lam Research's free-cash-flow margin is 25.0% of revenue over the trailing twelve months, ranking 5 of the 20 semiconductor materials & equipment companies we cover.
What is Lam Research's fair value (intrinsic value) per share?
Our discounted-cash-flow model of Lam Research's free cash flow after stock-based pay gives ~$220 per share in the base case, and ~$170–$290 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Lam Research's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Capital Management LLC and State Street Corp. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Lam Research buying back stock, and does it pay a dividend?
Lam Research spent $3.9B on share repurchases over the trailing twelve months, and its diluted share count fell 1.9% over the year.
What is Lam Research's market cap?
On November 2, 2026, Lam Research's market capitalisation was about $286B, with a price-to-earnings ratio of 33.9 and net debt of -$3.7B. Market figures come from third-party market data and may be delayed.
Does Lam Research pay a dividend?
Yes: Lam Research paid $1.3B in dividends over the trailing twelve months, a dividend yield of 0.46% and a payout ratio of 15.4%.
How much debt does Lam Research have?
Lam Research's debt-to-equity ratio is 26.8%, from its latest balance sheet (82.3% five years earlier). The financial health section below sets out its other solvency checks.
Who are Lam Research's competitors?
In our Semiconductor Materials & Equipment peer group, the companies closest to Lam Research are Applied Materials, Asml Holding NV, KLA Corporation, Teradyne and MKS Inc. The side-by-side comparison below sets their revenue, margins and growth against Lam Research's.
Are insiders buying or selling Lam Research stock?
Over the last 12 months, Lam Research's directors and officers reported 0 open-market purchases and 67 sales on Form 4. The insider trading page charts every trade.
When is Lam Research's next earnings date?
Around January 27, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Lam Research announces its own schedule.